MF
ANIK icon

Magnetar Financial’s Anika Therapeutics ANIK Stock Holding History

Magnetar Financial’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,666
Closed -$294K – 467
2019
Q4 		$294K Sell
5,666
-7,459
-57% -$433K 0.01% 448
2019
Q3 		$720K Sell
13,125
-1,216
-8% -$62.4K 0.02% 293
2019
Q2 		$583K Buy
+14,341
New +$523K 0.01% 275
2018
Q1 		– Sell
-5,203
Closed -$280K – 575
2017
Q4 		$280K Buy
+5,203
New +$288K 0.01% 531

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Magnetar Financial's ANIK Position: Q1 2020 in Review

Magnetar Financial sold out of Anika Therapeutics (ANIK) in Q1 2020, closing a stake of 5,666 shares — an estimated $294K sold.

Magnetar Financial first reported a position in ANIK in Q4 2017 and held it in 4 quarters. The position peaked at $720K in Q3 2019. 163 funds tracked by Wall St. Rank hold ANIK as of Q1 2020.

  • Magnetar Financial reported no remaining Anika Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Magnetar Financial sold 5,666 Anika Therapeutics shares in Q1 2020, an estimated $294K.
  • Magnetar Financial first reported a position in Anika Therapeutics in Q4 2017 and held it in 4 quarters.
  • Magnetar Financial's Anika Therapeutics position peaked at $720K in Q3 2019.
  • 163 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2020.

Based on Magnetar Financial's 13F filing for Q1 2020, filed 15 May 2020.